Medications
Two blood thinners at once: More risk with the same reward
More blood thinners aren't automatically better, another study confirms.
Apr 19, 2021
0
11
News tagged with anticoagulant therapy
Diseases, Conditions, Syndromes
COVID-19 causes pulmonary arterial thrombosis and damages other organs as well as the lungs
COVID-19, the disease caused by SARS-CoV-2, not only may lead to severe pneumonia but also to thrombosis in the lungs and, subsequently, to multi organ failure involving kidneys, liver and pancreas. These are the findings ...
May 18, 2020
0
75
Medications
Patient's place of residence matters when choosing cost-effective anticoagulation therapy
Appropriately selected anticoagulation therapy can help to reduce the medical costs of patients suffering from atrial fibrillation. A new study from the University of Eastern Finland shows that direct oral anticoagulants ...
Nov 27, 2019
0
0
Cardiology
Oral anticoagulants plus antiplatelets associated with poor outcome in atrial fibrillation
Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for antiplatelets, according ...
Aug 28, 2018
0
0
Cardiology
Lower thromboembolic risk with new A-fib after CABG versus NVAF
(HealthDay)—For patients post coronary artery bypass graft (CABG) surgery, new-onset postoperative atrial fibrillation (POAF) is associated with lower long-term thromboembolic risk than that seen among patients with nonvalvular ...
Mar 30, 2018
0
3
Cardiology
Anticoagulation guidance issued for cardiopulmonary bypass
(HealthDay)—Clinical practice guidelines for anticoagulation therapy for cardiopulmonary bypass (CPB) have been developed and were published in the February issue of the Annals of Thoracic Surgery.
Jan 22, 2018
0
3
Cardiology
Education and feedback improve use of stroke prevention drugs in atrial fibrillation
Education of healthcare providers and patients with atrial fibrillation has led to a 9 percent absolute increase in the use of anticoagulation therapies to reduce stroke, according to late-breaking results from the IMPACT-AF ...
Aug 28, 2017
0
0
Cardiology
Apixaban Tx cost in A-fib meets U.S. norms for reasonable value
(HealthDay)—Apixaban therapy is cost-effective for atrial fibrillation from the perspective of the U.S. health care system, according to a study published online March 29 in JAMA Cardiology.
Mar 31, 2017
0
0
Cardiology
Rivaroxaban reduces VTE recurrence compared with aspirin
In patients at elevated risk for a recurrence of potentially life-threatening blood clots, a low dose of the oral blood-thinning medication rivaroxaban reduced recurrences more than three-fold compared with aspirin, with ...
Mar 20, 2017
0
0
Cardiology
New study finds antithrombotic therapy has no benefit for low-risk atrial fibrillation patients
Findings from a large, community-based study show that antithrombotic therapy doesn't decrease low-risk atrial fibrillation patients' risk of suffering a stroke within five years. In fact, researchers found that low-risk ...
Mar 17, 2017
0
4
